American Health Packaging recalls Ranitidine Tablets, USP, 150 mg, 100 Tablets (10 tablets x 10 blister card), Rx Only, Packaged and Distributed by: Ameri
Recalled March 18, 2020 · FDA recall D-1003-2020 · American Health Packaging
Hazard
CGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA. · FDA Class II
Units
53,619 cartons
Sold at
Nationwide USA
Description
CGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
Product
Ranitidine Tablets, USP, 150 mg, 100 Tablets (10 tablets x 10 blister card), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-322-01; NDC Unit Dose Card: 60687-322-11
Manufacturer(s)
American Health Packaging
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →